Literature DB >> 22736108

Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.

Manzoor Ahmad Malik1, Showkat Ali Zargar, Balraj Mittal.   

Abstract

Esophageal cancer (EC) is a complex multifactorial disorder, where environmental and genetic factors play major role. NADPH:quinone oxidoreductase 1 (NQO1) and NRH:quinone oxidoreductase 2 (NQO2) are phase II cytosolic enzymes that catalyze metabolism of quinones, important in the detoxification of environmental carcinogens. A case-control study was performed to investigated the associations of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility to EC in a high-risk Kashmiri population of India in 135 EC patients and 195 unrelated healthy controls using PCR-RFLP. We also performed a meta analysis of nine published studies (1,224 cases and 1,740 controls) on NQO1 609C>T and evaluated the association between the NQO1 609C>T polymorphisms and esophageal cancer risk. A significant difference in NQO1 609C>T and NQO2 -3423G>A genotype distribution between EC cases and corresponding controls groups was observed (OR = 2.65; 95 % CI = 1.29-5.42 and OR = 1.88; 95 % CI = 1.02-3.49 respectively). Further, gene-gene interaction showed significantly increased risk for esophageal adenocarcinoma with variant genotypes of NQO1 609C>T and NQO2 -3423G>A polymorphisms and interaction with environmental risk factors revealed pronounced risk of EC with NQO1 609C>T TT genotype in high salted tea users of Kashmir valley (OR = 3.72, 95 % CI = 0.98-14.19). Meta analysis of NQO 609C>T polymorphism also suggested association of the polymorphism with EC in Asians as well as Europeans. In conclusion, NQO1 609C>T and NQO2 -3423G>A genetic variations modulate risk of EC in high-risk Kashmir population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736108     DOI: 10.1007/s11033-012-1781-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes.

Authors:  A Iida; A Sekine; S Saito; Y Kitamura; T Kitamoto; S Osawa; C Mishima; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China.

Authors:  Jian-Hui Zhang; Yan Li; Rui Wang; Helen Geddert; Wei Guo; Deng-Gui Wen; Zhi-Feng Chen; Li-Zhen Wei; Gang Kuang; Ming He; Li-Wei Zhang; Ming-Li Wu; Shi-Jie Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India).

Authors:  M Siddiqi; R Kumar; Z Fazili; B Spiegelhalder; R Preussmann
Journal:  Carcinogenesis       Date:  1992-08       Impact factor: 4.944

Review 4.  Epidemiology of digestive cancers in India. I. General principles and esophageal cancer.

Authors:  G Malkan; K M Mohandas
Journal:  Indian J Gastroenterol       Date:  1997-07

5.  Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran.

Authors:  H A Marjani; F Biramijamal; N Rakhshani; A Hossein-Nezhad; R Malekzadeh
Journal:  Genet Mol Res       Date:  2010-02-09

6.  An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.

Authors:  S Harada; C Fujii; A Hayashi; N Ohkoshi
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

Review 7.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

8.  Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley.

Authors:  Manzoor Ahmad Malik; Rohit Upadhyay; Dinesh Raj Modi; Showket Ali Zargar; Balraj Mittal
Journal:  Arch Med Res       Date:  2009-07       Impact factor: 2.235

9.  Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.

Authors:  Jianhui Zhang; Wolfgang A Schulz; Yan Li; Rui Wang; Rainer Zotz; Denggui Wen; David Siegel; David Ross; Helmut E Gabbert; Mario Sarbia
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

10.  High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits.

Authors:  M S Khuroo; S A Zargar; R Mahajan; M A Banday
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  14 in total

1.  Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.

Authors:  Kai Liu; Hui Tian; Kai-Zhong Yu; Wei-Yu Shen; Zhen-Chun Mao; Chen-Hua Jin; Hai-Bin Pan; Jin-Xian He
Journal:  Tumour Biol       Date:  2013-11-10

2.  Comparison and validation of genomic predictors for anticancer drug sensitivity.

Authors:  Simon Papillon-Cavanagh; Nicolas De Jay; Nehme Hachem; Catharina Olsen; Gianluca Bontempi; Hugo J W L Aerts; John Quackenbush; Benjamin Haibe-Kains
Journal:  J Am Med Inform Assoc       Date:  2013-01-26       Impact factor: 4.497

3.  Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis.

Authors:  Manzoor Ahmad Malik; Annapurna Gupta; Showkat Ali Zargar; Balraj Mittal
Journal:  Tumour Biol       Date:  2013-06-14

4.  NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.

Authors:  Hong-Yu Zhao; Yan Gu; Yong-Xiang Yi
Journal:  Tumour Biol       Date:  2013-10-19

5.  NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.

Authors:  Zhenling Li; Yue Zhang; Tiefeng Jin; Jiguang Men; Zhenhua Lin; Peng Qi; Yingshi Piao; Guanghai Yan
Journal:  BMC Cancer       Date:  2015-03-31       Impact factor: 4.430

6.  High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.

Authors:  Xuelian Cui; Lianhua Li; Guanghai Yan; Kai Meng; Zhenhua Lin; Yunze Nan; Guang Jin; Chunyu Li
Journal:  BMC Cancer       Date:  2015-04-09       Impact factor: 4.430

7.  Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.

Authors:  Jolien J M Freriksen; Jody Salomon; Hennie M J Roelofs; Rene H M Te Morsche; Jos W J van der Stappen; Polat Dura; Ben J M Witteman; Martin Lacko; Wilbert H M Peters
Journal:  J Hum Genet       Date:  2014-05-15       Impact factor: 3.172

8.  Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival.

Authors:  Zhi-Nong Jiang; Syed Minhaj Uddin Ahmed; Qin-Chuan Wang; Hong-Fei Shi; Xiu-Wen Tang
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

9.  The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.

Authors:  B Lajin; A Alachkar
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

10.  NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.

Authors:  Yue Ma; Jienan Kong; Guanghai Yan; Xiangshan Ren; Dan Jin; Tiefeng Jin; Lijuan Lin; Zhenhua Lin
Journal:  BMC Cancer       Date:  2014-06-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.